🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06336031
Recruiting Not applicable

Impact of Blood Phobia on Fainting Susceptibility

NCT06336031 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-03-30
Last updated
2025-05-15

Condition(s) studied

Syncope, VasovagalBlood, Injection, Injury Type Phobia

Investigational drug(s) / intervention(s)

blood-injection-injury (BII) phobia stimulineutral stimuli

blood-injection-injury (BII) phobia stimuli: 498 seconds of BII phobia-related images and videos will begin two-minutes prior to head-up tilt test, while in supine.

neutral stimuli: 498 seconds of neutral images and videos will begin two-minutes prior to head-up tilt test, while in supine.

Study summary

The primary purpose of this study is to characterize cardiovascular autonomic function to emotional stimuli (blood-injection-injury phobia \[needle phobia\]) during an orthostatic (upright) challenge in individuals with and without known needle phobia. It is well established that emotional stress can produce hypotensive (low blood pressure) reactions. Interestingly, these hypotensive reactions to venipuncture (even with minimal blood drawn), insulin injections, finger sticks for blood sugar monitoring, dental care, and vaccinations can affect up to a quarter of adults and appear to be uniquely associated with blood-injection-injury phobia rather than other phobias. These hypotensive reactions can ultimately lead to a vasovagal syncope (fainting) response, and lead to increased avoidance of medical and dental procedures as a result of this phobia. Ultimately, this has severe implications on public health and places additional strain on the Canadian healthcare system. Currently, there is limited understanding surrounding the initiation of this response. Additionally, a comprehensive profile of cardiovascular autonomic function during exposure to provoking stimuli during orthostatic stress has not been captured in the literature. We will test individuals with and without blood-injection-injury phobia using our standard approach while exposing them to emotional stimuli.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * male and female * 18 to 50 years old * those without a suspected BII fear and those with a suspected fear * english speaking Exclusion Criteria: * diagnosis of any cardiovacular or neurological disorder * menopausal * taking medication for a cardiovascular condition * if they are pregnant

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Simon Fraser University Burnaby British Columbia Recruiting

More Simon Fraser University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06336031 on ClinicalTrials.gov ↗ ← All trials in Canada